80 results
Keyword Opsumit Remove keyword
-
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 May 2018
European Medicines Agency, London, UK, from 14/05/2018 to 17/05/2018, Last updated: 14/05/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 20/06/2022 to 23/06/2022, Last updated: 18/08/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2021 to 10/06/2021, Last updated: 07/06/2021 -
List item
EMA/FDA/Health Canada joint workshop addressing unmet needs of children with pulmonary arterial hypertension
European Medicines Agency, London, UK, from 12/06/2017 to 13/06/2017, Last updated: 20/06/2017 -
List item
Committee for Orphan Medicinal Products (COMP): 8-10 October 2013
European Medicines Agency, London, UK, from 08/10/2013 to 10/10/2013, Last updated: 08/05/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 November 2014
European Medicines Agency, London, UK, from 03/11/2014 to 06/11/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 May 2015
European Medicines Agency, London, UK, from 04/05/2015 to 07/05/2015, Last updated: 13/03/2014 -
List item
Medicines for human use under evaluation 2014–2012
Last updated: 02/06/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 5-6 November 2013
European Medicines Agency, London, UK, from 05/11/2013 to 06/11/2013, Last updated: 08/05/2012 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2021 to 22/04/2021, Last updated: 07/12/2021 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 3-4 September 2013
European Medicines Agency, London, UK, from 03/09/2013 to 04/09/2013, Last updated: 08/05/2012 -
List item
COMP: meeting archive 2012-2014
Last updated: 15/06/2016 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/01/2022 to 27/01/2022, Last updated: 16/03/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 November 2015
European Medicines Agency, London, UK, from 03/11/2015 to 06/11/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 June 2015
European Medicines Agency, London, UK, from 08/06/2015 to 11/06/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 24-27 October 2016
European Medicines Agency, London, UK, from 24/10/2016 to 27/10/2016, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 May 2016
European Medicines Agency, London, UK, from 10/05/2016 to 13/05/2016, Last updated: 13/03/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 8-9 January 2013
European Medicines Agency, London, UK, from 08/01/2013 to 09/01/2013, Last updated: 08/05/2012 -
List item
Committee for Orphan Medicinal Products (COMP): 12-13 March 2013
European Medicines Agency, London, UK, from 12/03/2013 to 13/03/2013, Last updated: 08/05/2012 -
List item
Committee for Orphan Medicinal Products (COMP): 5-6 February 2013
European Medicines Agency, London, UK, from 05/02/2013 to 06/02/2013, Last updated: 08/05/2012 -
List item
Committee for Orphan Medicinal Products (COMP): 15-16 April 2013
European Medicines Agency, London, UK, from 15/04/2013 to 16/04/2013, Last updated: 08/05/2012 -
List item
Committee for Orphan Medicinal Products (COMP): 14-15 May 2013
European Medicines Agency, London, UK, from 14/05/2013 to 15/05/2013, Last updated: 08/05/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 September 2015
European Medicines Agency, London, UK, from 07/09/2015 to 10/09/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 May 2017
European Medicines Agency, London, UK, from 02/05/2017 to 05/05/2017, Last updated: 13/03/2014